Tevogen Bio believes that its investigational highly purified antigen-specific T cell therapy holds promise in the treatment of viral infections including COVID-19 and Influenza A. This collaboration aims to harness Tevogen's proprietary immunotherapy platform and Dr. Flomenberg's expertise in immunology, histocompatibility and pioneering work in the immunology of stem cell transplantation.
Read MoreTevogen Bio believes that its highly purified antigen specific T cell investigational therapy holds promise in the treatment of viral infections including COVID-19 and Influenza A
Read MoreThe NEMT broker operating in six states is working with various stakeholders to implement programs that will ease strain while adhering to social distancing guidelines
Read MoreHealthcare companies across multiple disciplines are working with Newswire to overcome the challenges of limited staffing and resources by utilizing Newswire's integrated media and marketing communications services.
Read More